144 related articles for article (PubMed ID: 26605964)
1. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty.
Gordon A; Kiss-Toth E; Stockley I; Eastell R; Wilkinson JM
Arthritis Rheum; 2008 Oct; 58(10):3157-65. PubMed ID: 18821666
[TBL] [Abstract][Full Text] [Related]
4. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
[TBL] [Abstract][Full Text] [Related]
5. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.
Ota N; Nakajima T; Nakazawa I; Suzuki T; Hosoi T; Orimo H; Inoue S; Shirai Y; Emi M
J Hum Genet; 2001; 46(5):267-72. PubMed ID: 11355017
[TBL] [Abstract][Full Text] [Related]
6. Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
Riemann K; Struwe H; Eisenhardt A; Obermaier B; Schmid KW; Siffert W
Pharmacogenet Genomics; 2008 Nov; 18(11):999-1008. PubMed ID: 18815590
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis.
Qi L; van Dam RM; Meigs JB; Manson JE; Hunter D; Hu FB
Hum Mol Genet; 2006 Jun; 15(11):1914-20. PubMed ID: 16644865
[TBL] [Abstract][Full Text] [Related]
8. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer.
Ahirwar D; Kesarwani P; Manchanda PK; Mandhani A; Mittal RD
Cancer Genet Cytogenet; 2008 Jul; 184(1):1-8. PubMed ID: 18558283
[TBL] [Abstract][Full Text] [Related]
9. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.
Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR
Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the H19 gene and the risk of bladder cancer.
Verhaegh GW; Verkleij L; Vermeulen SH; den Heijer M; Witjes JA; Kiemeney LA
Eur Urol; 2008 Nov; 54(5):1118-26. PubMed ID: 18262338
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients.
Sainz J; Pérez E; Gómez-Lopera S; López-Fernández E; Moratalla L; Oyonarte S; Jurado M
Cytokine; 2008 Mar; 41(3):268-78. PubMed ID: 18191407
[TBL] [Abstract][Full Text] [Related]
13. IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States.
Slattery ML; Curtin K; Baumgartner R; Sweeney C; Byers T; Giuliano AR; Baumgartner KB; Wolff RR
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):747-55. PubMed ID: 17416766
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
15. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
Mittal RD; Manchanda PK; Bhat S; Bid HK
BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
[TBL] [Abstract][Full Text] [Related]
17. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
18. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
19. Association of IL-6 gene polymorphisms and COPD in a Spanish population.
Córdoba-Lanús E; de-Torres JP; López-Aguilar C; Rodríguez-Pérez MC; Maca-Meyer N; Montejo-de-Garcini A; Aguirre-Jaime A; Pérez-Méndez L; Casanova C
Respir Med; 2008 Dec; 102(12):1805-11. PubMed ID: 18693004
[TBL] [Abstract][Full Text] [Related]
20. Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk.
Slattery ML; Curtin K; Sweeney C; Wolff RK; Baumgartner RN; Baumgartner KB; Giuliano AR; Byers T
Obesity (Silver Spring); 2008 Feb; 16(2):339-47. PubMed ID: 18239642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
